Analyst Ratings (Canada)
Analyst sentiment still shows a positive bias, as analysts are particularly optimistic on sectors tied to infrastructure, software, healthcare technology, utilities, banking, and precious metals, reflecting expectations for continued earnings growth and resilient economic conditions.
The upgrades to companies such as First Quantum Minerals, Royal Bank, Toronto-Dominion Bank, Information Services, and WELL Health suggest growing confidence in both cyclical and defensive areas of the market. Precious metals producers continue to benefit from a favorable outlook for gold and silver prices, while infrastructure and power-related companies are supported by long-term investment trends.
Analyst outlook appears to be positioning for a market environment characterized by moderate economic growth, stable interest rates, ongoing infrastructure spending, and continued investor interest in quality companies with strong cash flow generation and earnings visibility.
17 Analyst Updates
Advantage Energy (AAV:CA) – TD Securities maintained its Buy rating and C$14.00 target, reflecting continued confidence in the company’s natural gas production outlook and operational execution.
Aya Gold & Silver (AYA:CA) – Scotiabank maintained its Outperform rating and C$29.00 target, reflecting favorable silver market fundamentals and growth potential from ongoing project development.
Cogeco Communications (CCO:CA) – TD Securities maintained its Buy rating and C$83.00 target, highlighting the company’s stable cash flows and telecommunications infrastructure assets.
Colliers International (CIGI:CA) – Scotiabank maintained its Outperform rating and C$208.00 target, reflecting confidence in the company’s global real estate services platform and acquisition-driven growth strategy.
Dollarama (DOL:CA) – CIBC maintained its Outperform rating and C$202.00 target, supported by resilient consumer demand and continued store expansion opportunities.
FirstService (FSV:CA) – TD Securities maintained its Buy rating and C$283.00 target, with strong recurring revenue streams and long-term growth prospects across its property services businesses.
Information Services (ISC:CA) – RBC Capital raised its target price to C$51.00 from C$39.00 while maintaining a Sector Perform rating, reflecting improved earnings visibility and business momentum.
First Quantum Minerals (FM:CA) – Deutsche Bank raised its Buy target to C$50.00 from C$40.00, signaling increased optimism regarding copper prices and the company’s production outlook.
Lumine Group (LMN:CA) – TD Securities maintained its Buy rating and C$39.00 target, supported by the company’s software acquisition strategy and recurring revenue model.
Pan American Silver (PAAS:CA) – CIBC maintained its Outperform rating and C$130.00 target, reflecting a constructive outlook for precious metals and the company’s operating leverage to higher silver prices.
PharmaCorp RX (PCRX:CA) – Raymond James initiated coverage with an Outperform rating and C$0.70 target, highlighting potential upside from the company’s growth strategy and market opportunities.
Royal Bank of Canada (RY:CA) – Desjardins Securities raised its target price to C$280.00 from C$275.00, reflecting continued confidence in earnings growth and capital return potential.
SSR Mining (SSRM:CA) – RBC Capital lowered its target price to $55.00 from $62.00 while maintaining an Outperform rating, indicating a more conservative outlook despite favorable long-term fundamentals.
Toronto-Dominion Bank (TD:CA) – Desjardins Securities increased its target to C$167.00 from C$160.00, reflecting improving earnings expectations and valuation support.
TransAlta (TA:CA) – Scotiabank maintained its Outperform rating and C$27.00 target, reflecting favorable power market conditions and cash flow generation.
WELL Health Technologies (WELL:CA) – CIBC raised its target to C$6.00 from C$5.50 and maintained an Outperform rating, reflecting growing confidence in the company’s digital healthcare and AI-driven growth initiatives.
WELL Health Technologies (WELL:CA) – Stifel Nicolaus raised its target to C$8.25 from C$8.00 with a Buy rating, reflecting continued operational execution and expansion opportunities across its healthcare platform.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
